Reduced In-Hospital Mortality Following Intracoronary Streptokinase Treatment of Acute Myocardial Infarction

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Vascular and Endovascular Surgery

• Publication date

  1987-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/153857448702100309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Literature Abstracts

  2012cited by this paper
• Coronary Thrombolysis with TissueType Plasminogen Activator

  1987cited by this paper
• A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

  1986cited by this paper
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.

  1985cited by this paper
• The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report.

  1985cited by this paper
• Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial.

  1985cited by this paper
• Influence of baseline ejection fraction and success of thrombolysis on mortality and ventricular function after acute myocardial infarction.

  1984cited by this paper
• Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.

  1984cited by this paper
• Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.

  1984cited by this paper
• Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitals.

  1984cited by this paper
• Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.

  1983cited by this paper
• Ultrasonic assessment of the St. Jude prosthetic valve: M mode, two-dimensional, and Doppler echocardiography.

  1983cited by this paper
• Nonsurgical reperfusion in evolving myocardial infarction.

  1983cited by this paper
• Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarction.

  1983cited by this paper
• Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase.

  1983cited by this paper
• The international registry to support approval of intracoronary streptokinase thrombolysis in the treatment of myocardial infarction. Assessment of safety and efficacy.

  1983cited by this paper
• Intracoronary infusion of streptokinase in patients with acute myocardial infarction: effects of reperfusion on left ventricular performance.

  1981cited by this paper
• Intracoronary thrombolysis in evolving myocardial infarction.

  1981cited by this paper
• Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris

  1981cited by this paper
• Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: postprocedure management and hospital course in 204 patients.

  1981cited by this paper
• Non surgical coronary artery recanalization in acute transmural myocardial infarction.

  1981cited by this paper
• Clinical trials of thrombolytic agents in myocardial infarction.

  1973cited by this paper
• Care of the Feet

  1877cited by this paper

• FINANCIAL INCENTIVES TO IMPROVE MALARIA CASE MANAGEMENT : A REVIEW OF THE EVIDENCE Introduction and Overview

  2016cites this paper
• Causes of pediatric mortality and case-fatality rates in eight Médecins Sans Frontières-supported hospitals in Africa.

  2012cites this paper
• The Potential Impact of the Thrombolytic Era on Cardiac Rupture Complicating Acute Myocardial Infarction

  1994cites this paper
• Intravenous Streptokinase

  1990cites this paper